Literature DB >> 27537265

Microperimetry as an Outcome Measure in Choroideremia Trials: Reproducibility and Beyond.

Ioannis S Dimopoulos, Calvin Tseng, Ian M MacDonald.   

Abstract

PURPOSE: To determine test-retest repeatability of microperimetry testing (MP) in choroideremia (CHM) subjects using standard and personalized stimulus grids.
METHODS: Fifteen CHM subjects (28 eyes) underwent consecutive repeat examinations with the Macular Integrity Assessment (MAIA) microperimeter using a standard (10°) and a customized macular grid adapted to individual macular pathology. Repeatability of standard-grid mean (MS) and point-wise (PWS) sensitivity was determined and compared with age-matched controls (seven eyes), with PWS separately analyzed for loci within and outside the border of degeneration. Interpolated volumetric indices were used to estimate repeatability of customized grids and compare their performance to standard grids.
RESULTS: Test-retest measures of standard-grid MS yielded higher coefficients of variation (CV) in CHM subjects compared with controls (0.09 vs. 0.02). Volumetric indices from customized grids improved repeatability by driving CV values to 0.05 and close to 0.02 for region-of-interest (ROI) analysis. Variability of PWS was significantly higher in CHM, especially at the border of degeneration (10.68 vs. 4.74 dB at the central retina, P < 0.001).
CONCLUSIONS: Microperimetry testing in CHM shows high test-retest variation at the border of degeneration, which influences repeatability of MS measures. Volumetric measures from customized grids can improve reliability of both global and regional sensitivity assessment. Nevertheless, inherent test-retest variation of individual points needs to be taken into account when assessing potential functional decline and/or disease progression.

Entities:  

Mesh:

Year:  2016        PMID: 27537265     DOI: 10.1167/iovs.16-19338

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry.

Authors:  William S Tuten; Grace K Vergilio; Gloria J Young; Jean Bennett; Albert M Maguire; Tomas S Aleman; David H Brainard; Jessica I W Morgan
Journal:  Ophthalmol Retina       Date:  2019-05-08

2.  Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.

Authors:  Catherine Cukras; Henry E Wiley; Brett G Jeffrey; H Nida Sen; Amy Turriff; Yong Zeng; Camasamudram Vijayasarathy; Dario Marangoni; Lucia Ziccardi; Sten Kjellstrom; Tae Kwon Park; Suja Hiriyanna; J Fraser Wright; Peter Colosi; Zhijian Wu; Ronald A Bush; Lisa L Wei; Paul A Sieving
Journal:  Mol Ther       Date:  2018-07-07       Impact factor: 11.454

3.  Patient-reported outcome measures in inherited retinal degeneration gene therapy trials.

Authors:  Gabrielle D Lacy; Maria Fernanda Abalem; David C Musch; Kanishka T Jayasundera
Journal:  Ophthalmic Genet       Date:  2020-02-26       Impact factor: 1.803

Review 4.  The progress in techniques for culturing human limbal epithelial stem cells.

Authors:  Yan Shen; Qihua Le
Journal:  Hum Cell       Date:  2022-10-01       Impact factor: 4.374

5.  Characterizing the Natural History of Visual Function in Choroideremia Using Microperimetry and Multimodal Retinal Imaging.

Authors:  Jasleen K Jolly; Kanmin Xue; Thomas L Edwards; Markus Groppe; Robert E MacLaren
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

Review 6.  Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease.

Authors:  Yesa Yang; Hannah Dunbar
Journal:  Ophthalmologica       Date:  2021-02-10       Impact factor: 3.250

7.  Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity.

Authors:  Amandeep Singh Josan; Thomas M W Buckley; Laura J Wood; Jasleen K Jolly; Jasmina Cehajic-Kapetanovic; Robert E MacLaren
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

Review 8.  Multimodal Imaging in Choroideremia.

Authors:  Katharina G Foote; Austin Roorda; Jacque L Duncan
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 3.650

9.  Individual Test Point Fluctuations of Macular Sensitivity in Healthy Eyes and Eyes With Age-Related Macular Degeneration Measured With Microperimetry.

Authors:  Mirella Telles Salgueiro Barboni; Zsuzsanna Szepessy; Dora Fix Ventura; János Németh
Journal:  Transl Vis Sci Technol       Date:  2018-04-23       Impact factor: 3.283

10.  RPGR-Associated Dystrophies: Clinical, Genetic, and Histopathological Features.

Authors:  Xuan-Thanh-An Nguyen; Mays Talib; Mary J van Schooneveld; Joost Brinks; Jacoline Ten Brink; Ralph J Florijn; Jan Wijnholds; Robert M Verdijk; Arthur A Bergen; Camiel J F Boon
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.